Dados B3 › MLAS3 × OIBR3
MLAS3 × OIBR3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | MLAS3 | OIBR3 | year |
|---|---|---|---|
| ROE | 28.0% | -243.5% | 2021 |
| ROIC | 2.9% | -91.3%! | 2022 |
| ROA | -6.0% | 41.9%! | 2024 |
| Gross margin | 23.2% | -45.7%! | 2024 |
| EBIT margin | -0.6% | -61.5%! | 2024 |
| Net margin | -9.5% | 302.2%! | 2024 |
| Net debt/EBITDA | -0.44x | 11.73x | 2021 |
| Current ratio | 2.31x | 1.00x! | 2024 |
| Revenue growth (1y) | -3.2% | -25.3%! | 2024 |
| Revenue growth (5y CAGR) | 6.6% | -21.2%! | no year where both have it (2025 × 2024) |
| Piotroski F-Score | 6/9 | 5/9! | 2024 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | MLAS3 | OIBR3 | year |
|---|---|---|---|
| P/E | — | 0.00x | 2025 × 2024 |
| P/B | 0.37x | — | 2025 × 2024 |
| EV/EBITDA | 5.71x | — | 2025 × 2024 |
| FCF yield | 6.8% | -352,559.1% | 2025 × 2024 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 06:39 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 06:39 UTC. If this does not match /saude, you are reading a cached copy.